Biotech
Evelo Biosciences Appoints Industry Veteran Jonathan Zung, Ph.D. as Chief Development Officer
CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered product candidates which act in the small intestine to drive systemic more...
Biotech
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
Expands Pipeline Beyond Ophthalmology with PP-001 , a Clinical Stage, Best-in-Class DHODH Inhibitor PP-001 Leverages a Validated Immune Modulating Mechanism Optimized for Increased Specificity and Picomolar Potency to Avoid Off-Target Side Effects Acquisition Strengthens Leadership more...
Biotech
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – STND, EIDX, WTRE, ARA, CGIX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – STND, EIDX, WTRE, ARA, CGIX PR Newswire NEW YORK , Dec. 19, 2020 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it more...
Biotech
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – ALXN, ELY, CLCT, CBLI
NEW YORK, NY / ACCESSWIRE / December 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) concerning potential violations of the more...
Biotech
Kaskela Law LLC Announces Investigation of Aptevo Therapeutics Inc. (APVO) and Encourages Shareholders to Contact the Firm
PHILADELPHIA, PA / ACCESSWIRE / December 19, 2020 / Kaskela Law LLC announces that it is investigating Aptevo Therapeutics Inc. (“Aptevo”) (NASDAQ:APVO) on behalf of the company’s shareholders. The investigation seeks to determine whether Aptevo more...
Biotech
LOSS NOTICE DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Celsion Corporation Investors to Seek Counsel Before Important December 29 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CLSN
NEW YORK, NY / ACCESSWIRE / December 19, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Celsion Corporation (NASDAQ:CLSN) between November 2, 2015 and July 10, more...
Biotech
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 19, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Celsion Corporation (“Celsion” or “the Company”) (NASDAQ:CLSN) more...
Biotech
WeissLaw LLP Reminds EIGI, GV, CGIX and ROCH Shareholders About Its Ongoing Investigations
WeissLaw LLP Reminds EIGI, GV, CGIX and ROCH Shareholders About Its Ongoing Investigations PR Newswire NEW YORK , Dec. 18, 2020 /PRNewswire/ — If you own shares in any of the companies listed above and more...
Biotech
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO) PR Newswire BENSALEM, Pa. , Dec. 18, 2020 /PRNewswire/ — Law Offices of more...
Biotech
LOOMING DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Celsion Corporation – CLSN
NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Celsion Corporation (NASDAQ: CLSN) between November 2, 2015 and July 10, more...